Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
API 31510 topical cream in superficial basal cell carcinoma
NCT00604890Phase 2Completed
- Sponsor
- BPGbio
- Start
- Mar 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ubidecarenone nanodispersion in basal cell carcinoma (BCC), sponsored by BPGbio. Started Mar 2008; status: completed.
02
Drugs
ubidecarenone nanodispersion
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT00604890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604890.